Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Silke Salavati

Silke Salavati

The Roslin Institute University of Edinburgh UK

Alex Maughan

Alex Maughan

Foundation Doctor at Papworth Hospital UK

Fred Tenover

Fred Tenover

Scientific Affairs Cepheid USA

Teresa Coque

Teresa Coque

Hospital Ramon Y Cajal Spain

Martin Duerden

Martin Duerden

Bangor University UK

David Denning

David Denning

University of Manchester UK

Astrid Pentz-Murr

Astrid Pentz-Murr

GARDP Switzerland

Kartik Cherabuddi

Kartik Cherabuddi

University of Florida USA

Antibiotics 2021

About Conference


Antibiotics 2021 welcomes attendees, participants, students, speakers, organizing committee members, delegates from all over the world. We welcome you and appreciate your participation at the 8th World Congress and Exhibition on Antibiotics and Antibiotic Resistance, which is going to be held during March 08-09, 2021 is a Webinar event and it will be organized around the theme "Current Research: Tackling Antibiotic Resistance and COVID-19" which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

We organize a series of 3000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Antibiotics 2021 is intended to honour prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Pharmacology.

Young Research’s Awards at Antibiotics 2021 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Antibiotics 2021.

YRF Registration benefits:

  • Our conferences provide best Platform for your research through oral presentations.
  • Share the ideas with both eminent researchers and mentors.
  • Young Scientist Award reorganization certificate and memento to the winners
  • Young Scientists will get appropriate and timely information by this Forum.
  • Platform for collaboration among young researchers for better development
  • Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

YRF Registration Deadline:

Till December 30 – $399

Till January 30 – $499

Till March 07– $599

Why to attend?

Antibiotics 2021 is a platform to discuss and learn about the latest advancements in the field of Antibiotics and Antibiotic Resistance as the world’s consideration turned regarding the urgency of new antibiotics as the antimicrobial resistance is growing day by day. Many developed nations and International health organizations are trying to focus of the current situation and making new policies to prevent the adverse effects of Antibiotic resistance.

The 2-day conference gathers Researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, Pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working in the field of Antibiotics to know the latest developments and the current situation of the Antibiotic resistance problem.

Target Audience

Healthcare Students, Scientists, and professors

Doctors

Microbiologist

Infectious diseases specialists

Antimicrobial scientists

Pharmacists

Public health experts

Laboratorist

Bacteriology Researchers

Faculty of Bacteriology and Infectious Diseases

Medical Colleges

Healthcare Associations and Societies

Business Entrepreneurs

Conference Opportunities

Speaker Presentations

Poster Display

Symposium hosting (4-5 member Teams)        

Workshop organizing

For Researchers and Faculty Members

For Universities, Associations & Societies:

Association Partnering

Collaboration Proposals        

Academic Partnering 

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)       

Young Researcher Forum (YRF Award to the best presenter)

Student Attendee      

Group Registrations

For Business Delegates:

Speaker Presentations

Symposium Hosting

Book Launch Event

Networking opportunities     

Audience participation

For Product Manufacturers:

Exhibitor and Vendor Booths

Sponsorships opportunities

Product launch

Workshop organizing

Scientific Partnering

Marketing and Networking with clients

Scientific Session/Tracks

After a successful conference of Antibiotics 2021, we are currently bringing forth “8th World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2021) slated on March 08-09, 2021. Antibiotics 2021 aims to gather attendees, participants, students, and speakers, organizing committee members, delegates, most elegant societies and industries, renowned and honourable persons from top universities across the globe to London, UK. We are delighted to invite you to our 8th World Congress and Exhibition on Antibiotics and Antibiotic Resistance on March 08-09, 2021 is a Webinar event.

Antibiotics 2021 covers various aspects of Antibiotics, Antimicrobial Therapy, Antimicrobial Peptides, Antibiotics for Emerging & Re-Emerging Diseases, Drug Discovery Technologies in Antibiotics, Antibiotic production and Delivery method, Microorganisms Producing Antibiotics, Applications of Antibiotics, Pharmacokinetics and Pharmacodynamics of Antimicrobial drugs, Veterinary Importance of Antibiotics, Antibiotics for Oncology, Antibiotics Overuse and Resistance, Antibiotic-resistant Bacterial infections, Mechanism and Evolution of Antibiotic Resistance, Genetics of Antibiotic Resistance, Clinical Trials of Antibiotics, Clinical and Economic Burden of Antibiotic Resistance, Antibiotics: Market Analysis & Business Opportunities, Prevention and Control of Antibiotic resistance, New antibiotics and non-antibiotic approaches, Current research in antibiotic resistance, The Next Generation Approach of Antibiotics, Developing Alternatives to Antibiotics.

Track 1: ANTIBIOTICS

Antibiotics are a type of antimicrobials used in treatment and prevention of bacterial infections. They may inhibit or kill the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to animals and humans also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as influenza or common cold, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2020 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 2: ANTIMICROBIAL THERAPY

An antimicrobial therapy kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans. Antimicrobial agents are some of the most widely, and often used therapeutic drugs worldwide. It contributes significantly to the quality of life of many people and reduces the morbidity and mortality due to infectious disease. The remarkable success of antimicrobial therapy has been achieved with comparatively little toxicity and expense.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 3: ANTIMICROBIAL PEPTIDES

Antimicrobial peptides (AMPs), also called Host Defence Peptides (HDPs) are part of the innate immune response found among all classes of life. AMPs have a broad spectrum of targeted organisms ranging from viruses to parasites. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as Immunomodulatory.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 4: ANTIBIOTICS FOR EMERGING & RE-EMERGING DISEASES

Antimicrobial agents play vital roles in decreasing human morbidity and mortality resulting from infectious diseases. Emerging and re-emerging infectious diseases are global problems, and a constant supply of new antibiotics is essential if we are to combat these diseases successfully. The session is open to discuss on synthetic tailoring, discovery of new scaffolds, designing screens that avoid rediscovering old scaffolds, repurposing libraries of synthetic molecules for use as antibiotics, Exploring microbial niches for products, molecular target selection, improving libraries to overcome resistance, Safety and efficacy, Vaccines available for the diseases, Phage’s and parasitic bacteria, Epidemiology and spread of microbes and resistance traits.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 5: DRUG DISCOVERY TECHNOLOGIES IN ANTIBIOTICS

Infectious diseases account for nearly one fifth of the worldwide death toll every year. The constant increase of drug‐resistant pathogens is a big challenge for treatment of infectious diseases. In addition, outbreaks of infections and new pathogens are potential threats to public health. Lack of effective treatments for drug‐resistant bacteria and recent outbreaks of Ebola and Zika viral infections have become a global public health concern. The number of newly approved antibiotics has decreased significantly in the last two decades compared with previous decades. In parallel with this, is an increase in the number of drug‐resistant bacteria. For these threats and challenges to be countered, new strategies and technology platforms are critically needed. Drug remodelling has emerged as an approach for rapid identification of effective therapeutics to treat the infectious diseases.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

 Track 6: ANTIBIOTIC PRODUCTION AND DELIVERY METHOD

Antibiotic production can be grouped into three methods: natural fermentation, semi-synthetic, and synthetic. As more and more bacteria continue to develop resistance to currently produced antibiotics, research and development of new antibiotics continues to be important. In addition to research and development into the production of new antibiotics, repackaging delivery systems is important to improving efficacy of the antibiotics that are currently produced. Improvements to this field have seen the ability to add antibiotics directly into implanted devices, aerosolization of antibiotics for direct delivery, and combination of antibiotics with non-antibiotics to improve outcomes.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 7: MICROORGANISMS PRODUCING ANTIBIOTICS

Antibiotic is one of the most important commercially exploited secondary metabolites produced by bacteria, fungi and Streptomyces and employed in a wide range. Most of the antibiotics used today are from the microorganisms that live in soil. Bacteria are easy to isolate, culture, maintain and to improve their strain. The main producers of the microbial metabolites, the actinobacteria, fungi and other filamentous bacteria, represent inexhaustible sources for the future.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 8: APPLICATIONS OF ANTIBIOTICS

Antibiotics are used commercially, potentially useful in medicine for activities other than their antimicrobial action. They are used as antitumor agents, enzyme inhibitors including powerful hypocholesterolemic agents, immunosuppressive agents, and anti-migraine agents, etc. This session mainly is to focus on the application of anti-bacterials, antifungals, and anti-cancers with their clinical use to date, including the development history, side effects, and etc. The antibiotics were classified by their uses, structure types, and molecular mechanisms.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 9: PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIMICROBIAL DRUGS

The pharmacodynamics of an antimicrobial drug relates its pharmacokinetics to the time course of the antimicrobial effects at the site of the infection. Knowledge of the drug's antimicrobial pharmacodynamics effects provides a more rational basis for determination of optimal dosing regimens in terms of the dose and the dosing interval than do the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) determined in vitro. This session mainly focus on pharmacokinetics, antimicrobial pharmacodynamics, the effect of pharmacodynamics on the emergence of resistant bacterial subpopulations, and the development of pharmacodynamics breakpoints for use in the design of trials of these drugs and in the treatment of infected patients.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 10: VETERINARY IMPORTANCE OF ANTIBIOTICS

Antibiotics are used in livestock production for two basic reasons: disease treatment and disease prevention. Just like humans, animals are prone to bacterial infections. As in human medicine, antibiotics are used to effectively treat those infections. In livestock production, antibiotics can also be used to prevent disease. There are times in an animal’s life, such as weaning, where certain diseases can be very common. Antibiotics are sometimes used to prevent these diseases from becoming established in the first place.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 11: ANTIBIOTICS FOR ONCOLOGY

An antibiotic is a chemical made by a microbe that antagonizes the growth of other cells.  They reduce the viability and clonal expansion of cancer stem cells is of broad importance, as cancer stem cells are increasingly accepted as a distinct cell type that gives rise to therapy resistance, tumour recurrence and distant metastasis. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds which are necessary for the cell. Antibiotics are used against leukaemia, bladder cancer, testicular cancer, and sarcomas.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 12: ANTIBIOTICS OVERUSE AND RESISTANCE

Antibiotic overuse is when antibiotics are used when they're not needed. Antibiotics are one of the great advances in medicine. But overprescribing them has led to resistant bacteria (bacteria that are harder to treat). Some germs that were once very responsive to antibiotics have become more and more resistant. Antibiotic overuse is a key driver of antimicrobial resistance. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 13: ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS

Antibiotics have been used to treat people with infectious diseases caused by bacteria. However, certain antibiotics have been used so widely and for so long that some bacteria that cause disease have become resistant to them, making these treatments less effective. Antibiotic resistance occurs when the medication loses its ability to kill bacteria. As a result, the organisms continue to grow and cause infection, even in the presence of the antibiotic.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 14: MECHANISM AND EVOLUTION OF ANTIBIOTIC RESISTANCE

Antibiotics target essential cellular functions but bacteria can become resistant by acquiring either exogenous resistance genes or chromosomal mutations. Resistance mutations typically occur in genes encoding essential functions; these mutations are therefore generally detrimental in the absence of drugs. However, bacteria can reduce this handicap by acquiring additional mutations, known as compensatory mutations. Genetic interactions (epistasis) either with the background or between resistances (in multiresistant bacteria) dramatically affect the fitness cost of antibiotic resistance and its compensation, therefore shaping dissemination of antibiotic resistance mutations.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 15: GENETICS OF ANTIBIOTIC RESISTANCE

Acquired bacterial antibiotic resistance can result from the mutation of normal cellular genes, the acquisition of foreign resistance genes, or a combination of these two mechanisms. The most common resistance mechanisms employed by bacteria include enzymatic degradation or alteration of the antimicrobial, mutation in the antimicrobial target site, decreased cell wall permeability to antimicrobials, and active efflux of the antimicrobial across the cell membrane. The spread of mobile genetic elements such as plasmids, transposons, and integrons has greatly contributed to the rapid dissemination of antimicrobial resistance among several bacterial genera of human and veterinary importance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 16: CLINICAL TRIALS OF ANTIBIOTICS

There has been an increasing use of antibiotics in all areas of medicine. Clinical trials to test antibiotics are normally of a less than satisfactory quality. The main objective of initial clinical trials, at least, is to provide the pharmaceutical company with sufficient information to persuade the regulatory authority that the drug is effective, safe and well produced.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 17: CLINICAL AND ECONOMIC BURDEN OF ANTIBIOTIC RESISTANCE

Knowledge of the clinical and economic impact of antimicrobial resistance is useful to influence programs and behaviour in healthcare facilities, to guide policy makers and funding agencies, to define the prognosis of individual patients and to stimulate interest in developing new antimicrobial agents and therapies. There are a variety of important issues that must be considered when designing or interpreting studies into the clinical and economic outcomes associated with antimicrobial resistance. One of the most misunderstood issues is how to measure cost appropriately. This session mainly focus on variety of important issues that must be considered when designing or interpreting studies of the clinical and economic outcomes associated with antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 18: ANTIBIOTICS: MARKET ANALYSIS & BUSINESS OPPORTUNITIES

Antibiotic medicines are among the most prescribed courses worldwide, in fighting bacterial infections, primarily in outpatient settings. Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. The antibiotics market was valued at USD 39.8 billion in 2015 and is expected to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 19: PREVENTION AND CONTROL OF ANTIBIOTIC RESISTANCE       

Antimicrobial resistance is a complex problem with many diverse contributing factors. It is major cause of health concerns adding cost to oneself and to the community, directly or indirectly. Prevention is still the best tool to reduce the infection spread and thereby AMR. Along with rational use of existing antimicrobial drugs, development of new effective compounds and new diagnostic technology is the need. Joint efforts from patients, prescribers and individuals to international regulators and policy makers are needed to fight against the globally spreading antimicrobial resistance.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 20: NEW ANTIBIOTICS AND NON-ANTIBIOTIC APPROACHES

New antibiotics need to be developed, which doctors will be able to use when existing drugs no longer work. Non-antibiotic treatments can also reduce our dependence on antibiotics. The government encourages companies to develop new drugs and treatments. New technologies can also help prevent infections.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 21: CURRENT RESEARCH IN ANTIBIOTIC RESISTANCE

Antibiotic overuse and misuse has led to a growing number of bacteria in humans, animals and the environment that are resistant to life-saving antimicrobial therapies. Urgent action is needed to halt the development of resistance, and to accelerate new treatments for bacterial infection. Research includes epidemiology of both Gram-negative and Gram-positive infections, genetic mechanisms of resistance, evolution and transmission in the hospital setting, as well as the community, and antimicrobial stewardship.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 22: THE NEXT GENERATION APPROACH OF ANTIBIOTICS

As research into antibiotic resistance expands, it is important to adopt an explicitly proactive approach to antibiotic resistance identification and surveillance, as well as antibiotic therapy development. This proactive approach involves using a combination of functional metagenomics, next-generation sequencing and cutting-edge computational methods to monitor the evolution and dissemination of resistance before a given resistance determinant emerges in a pathogen or in the clinical setting, as well as proactively developing next-generation therapies that target these resistance determinants. Recent advances in the field highlight the promise that the next generation of resistome studies hold for characterizing and countering emerging resistance threats.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology

Track 23: DEVELOPING ALTERNATIVES TO ANTIBIOTICS

Alternatives to antibiotics are broadly defined as any substance that can be substituted for therapeutic drugs that are increasingly becoming ineffective against pathogenic bacteria due to antimicrobial resistance. Although antibiotics remain an essential tool for treating animal diseases on the farm, the availability of effective medical interventions to prevent and control animal diseases is one of the most significant challenges facing veterinary medicine in the 21st century. Phytochemicals as antibiotic alternatives to promote growth and enhance host health. Innovative drugs, chemicals, and enzymes within the animal production chain. Vaccines as alternatives to antibiotics for food producing animals. Also recent research provides numerous possibilities for the application nanomaterials in broad-spectrum eradication of pathogenic bacteria with many applications such as skin pathogen infection, implant sterilization, and wastewater treatment.

Related Conferences: Antibiotics Conferences | Antibiotic Resistance Conferences | Antibiotics Congress | Conferences on Antibiotics | Drug Resistance Meetings | Antibiotics Conferences USA | Antibiotics 2021 | Antibiotics Conferences Europe | Antibacterial Events | Antibiotics Meetings | Antibiotics Symposium | Antimicrobial Conference | Antimicrobial Event | Antimicrobial Congress | Antimicrobial Resistance | Antimicrobial Resistance Conference

Related Societies:

Societies in USA:

Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), Center for a Livable Future (CLF), Infectious Diseases Society of America

Societies in Europe:

The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReAct – Action on Antibiotics, Compassion in World Farming (CIWF)

Societies in Asia and Pacific:

Australian Society of Antimicrobials, Australasian Society for Infectious Diseases, The Philippine Society for Microbiology, Israel Society for Microbiology (ISM), Chinese Society for Microbiology (CSM), Iranian Society of Microbiology.

Market Analysis

Antibiotics 2021 Market Analysis

The global antibiotics market was valued at USD 42,653.89 million in 2018, and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%.The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2024 growing at a CAGR of 1% during the given forecast period. Rising pervasiveness of irresistible illnesses particularly in creating locales, for example, Asia Pacific and MEA is foreseen to contribute towards showcase development.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global pharmaceutical market. However, the antibiotics market is maturing; it showed an average annual growth of 4% over the past 5 years, compared with a growth of 16.7% and of 16.4% for antiviral drugs and vaccines, respectively.

Over 15.0% of the passing’s, in kids underneath the age of five, are assessed to be because of pneumonia and as indicated by the insights given by the WHO around 9.2 million passing’s were recorded in 2015. Like tuberculosis, the most elevated commonness of the sickness is recognized to be in the South Asian and Sub-Saharan locales. At present, the required anti-infection treatment is accessible just to 33% of the tainted populace, subsequently expanding the illness trouble.

The major driving factors of Antibacterial Drugs Market are as follows:

  • There is a very high prevalence of infectious diseases.
  • The research and development activities have increased.
  • Product differentiation through various methods.
  • Increased government support.

The restraining factors of Antibacterial drugs Market is as follows:

Importance and Scope

Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.

Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.

Target Audience

Related Companies

  1. Gilead Sciences
  2. Pfizer
  3. Abbott Laboratories
  4. Merck & Co
  5. Eli Lilly
  6. Astellas Pharma
  7. Teva Pharmaceutical Industries
  8. Boehringer Ingelheim
  9. Roche
  10. Mylan
  11. 3-D Matrix
  12. Agilent
  13. BeiGene
  14. BioDuro
  15. Fosun Pharma

Related Associations and Societies

  1. World Health Organization
  2. U.S. Food and Drug Administration (FDA)
  3. Natural Resources Defense Council (NRDC)
  4. Infectious Diseases Society of America
  5. World Health Assembly
  6. Center for a Livable Future (CLF)
  7. The Humane Society of the United States (HSUS)
  8. Alliance for the Prudent Use of Antibiotics
  9. Civil Society Organisations
  10. British Society for Antimicrobial Chemotherapy
  11. Pediatric Infectious Diseases Society
  12. Royal Society of Medicine
  13. European Society of Clinical Microbiology and Infectious Diseases
  14. CAESAR (Central Asian & Eastern European Surveillance of Antimicrobial Resistance)
  15. WAAAR - World Alliance Against Antibiotic Resistance
  16. ReAct – Action on Antibiotic Resistance
  17. American Medical Association

Past Conference Report

Antibiotics 2020

Conference Series LLC Ltd hosted the “7th World Congress and Exhibition on Antibiotics and Antibiotics Resistance”, during March 16-17, 2020 at London, UK with the theme, “Focusing on Novel Strategies in Antibiotics Research”, which was a great success. Eminent keynote speakers from various reputed institutions and organizations addressed the gathering with their resplendent presence.

We extend our grateful thanks to all the momentous speakers, conference attendees who contributed towards the successful run of the conference.

Antibiotics 2020 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various latest and exciting innovations in all areas of Pharmacology and Microbiology.

Antibiotics Organizing Committee extends its gratitude and congratulates the Honorable Moderators of the conference.

Conference Series LLC Ltd extends its warm gratitude to all the Honorable Guests and Keynote Speakers of “Antibiotics 2020”.

  • Sanjib Bhakta, University of London and UCL, UK
  • Nida’a M A Wadi, National University of Sciences and Technology “NUST”, Oman
  • Larysa V Iakovlieva, National University of Pharmacy, Ukraine

Conference Series LLC Ltd is privileged to felicitate Antibiotics 2020 Organizing Committee, Keynote Speakers, Chairs & Co-Chairs and also the Moderators of the conference whose support and efforts made the conference to move on the path of success. Conference Series LLC LTD thanks every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Pharmacology and Microbiology.

Conference Series LLC Ltd is glad to announce its “8th International Conference on Antibiotics and Antibiotic Resistance, which will be held during March 08-09, 2021 which is a Webinar Event. We cordially welcome all the eminent researchers, Healthcare Students, Scientists, and professors, Microbiologists, Infectious diseases specialists, Antimicrobial scientists, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, Pharma and labs Software developing companies, Training Institutes, Young researchers, Data Management Companies, Hospital General Counsel, Healthcare Associations and Societies, Manufacturing Medical Devices Companies, students and delegates to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Pharmacology.

Bookmark your dates for “Antibiotics 2021” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 08-09, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Drug Metabolism & Toxicology Advances in Antibiotics & Antibodies Drug Designing: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner